Thank you for attending ECIO 2024
We appreciate your attendance and we sincerely value the time and focus you have given us. It provided a valuable chance to present our innovative solutions and scientific evidence, showing our commitment to improving personalized patient treatments and contributing significant value to healthcare.
|
|
|
|
![]() |
Replay our symposium to:
Explore the primary features of the first resorbable drug-eluting microspheres.
Understand the advantages of feeding artery reperfusion through clinical cases.
Gain insights from the BIOPEARL-ONE clinical study.
Learn from the panel's perspective on how BioPearlTM microspheres contribute to the evolving role of TACE.
|
![]() |
Panel of experts |
Prof. Philippe Pereira SLK-Kliniken GmbH
Heilbronn, Germany |
|
|
|
Dr. Gontran Verset Institut Paoli-Calmettes
Marseille, France |
|
|
|
Prof. Irene Bargellini Candiolo Cancer Institute IRCCS
Turin, Italy |
|
|
|
Ty Naccarato Microvention Research and Development
Aliso Viejo, USA |
|
|
|
Dr. Tommaso Cascella Istituto Nazionale Tumori Milan, Italy |
|
|
|
Prof. Roberto Iezzi Policlinico Universitario Agostino Gemelli Rome, Italy |
|
|
|
|
|
|
Further information about our session duringECIO 2024 |
![]() |
|
|
|
